CJC-1295
A growth-hormone-releasing hormone analog studied for pulsatile GH secretion.
Research Overview
CJC-1295 (without DAC) is a modified analog of growth-hormone-releasing hormone (GHRH) fragment 1-29. It acts as a GHRH-receptor agonist on pituitary somatotrophs, studied for its capacity to stimulate growth-hormone release while preserving the natural pulsatile pattern.
The amino-acid substitutions improve enzymatic stability relative to native GRF. Research is confined to endocrine-signaling and pituitary-secretion models.
Specifications
| Compound | CJC-1295 (Modified GRF 1-29 (no DAC)) |
| Classification | Endocrine research compound |
| Molecular weight | 3,367.8 g/mol |
| Sequence / Form | Modified GRF(1-29) |
| Purity | ≥99% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
Quality Documentation
Every released lot is supported by quality-control documentation. Certificate access is presented by compound and lot where available. Cold-chain shipping is available where required; inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
Research Use Only
This product is offered strictly for laboratory research use. It is not a drug, food, cosmetic, supplement, or consumer product, and is not intended for human or veterinary use.
